Moderna Inc

$28.34
(as of Mar 31, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Moderna Inc

Stock Price
$28.34
Ticker Symbol
MRNA
Exchange
NASDAQ

Industry Information for Moderna Inc

Sector
Healthcare
Industry
Biotechnology

Company Description for Moderna Inc

Country
USA
Full Time Employees
5,800

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Fundamentals for Moderna Inc

Market Capitalization
$12,031,708,160
EBITDA
$-3,756,000,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
32.47
Earnings per Share
$-9.28
Earnings per Share Estimate Next Year
Profit Margin
-110.04%
Shares Outstanding
386,623,008
Percent Owned by Insiders
7.27%
Percent Owned by Institutions
72.76%
52-Week High
52-Week Low

Technical Indicators for Moderna Inc

50-Day Moving Average
200-Day Moving Average
RSI
41.11
2.09

Analyst Ratings for Moderna Inc

Strong Buy
5
Buy
3
Hold
14
Sell
3
Strong Sell
1

News About Moderna Inc

Mar 31, 2025, 7:00 AM EST
CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. See more.
Mar 29, 2025, 4:17 PM EST
We recently published a list of Jim Cramer Discussed These 9 Stocks Recently. See more.
Mar 27, 2025, 1:13 PM EST
We recently published a list of Did Jim Cramer Nail or Miss These 14 Stocks? See more.
Mar 27, 2025, 10:27 AM EST
We recently published a list of 10 Stocks To Trade Without Tariffs And Interest Rate Fears. See more.